Vanda Pharmaceuticals
VNDA
VNDA
110 hedge funds and large institutions have $622M invested in Vanda Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+1
Holders Change %
+0.92%
% of All Funds
3.16%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
24
Increased
38
Reduced
37
Closed
23
Calls
$40.9M
Puts
$7.66M
Net Calls
+$33.2M
Net Calls Change
-$10.4M
Top Buyers
| 1 |
PC
1
Paulson & Co
New York
|
$51.8M |
| 2 |
SCA
2
Signpost Capital Advisors
New York
|
$27.3M |
| 3 |
3
T. Rowe Price Associates
Baltimore,
Maryland
|
$55.4M |
| 4 |
KCM
4
Kingdon Capital Management
New York
|
$28.2M |
| 5 |
DM
5
Deerfield Management
New York
|
$17.6M |
